Gabriela Carla dos Santos Costa

Gabriela Carla dos Santos Costa

Auto-generated profile, based on publicly available information

Gabriela Carla dos Santos Costa

Hospital Alfa, Brazil

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2023 in Jornal Brasileiro de Pneumologia
Verified
Journal Article
Open access
GCGuilherme Jorge Costa
Guilherme Jorge Costa
José Roberto da Silva JuniorJosé Roberto da Silva Junior
José Roberto da Silva Junior
CSCaio Cesar Arruda da Silva
Caio Cesar Arruda da Silva
TLTiago Pessoa Ferreira de Lima
Tiago Pessoa Ferreira de Lima
MCMariana Menezes Costa
Mariana Menezes Costa
MSMozart Júlio Tabosa Sales
Mozart Júlio Tabosa Sales
Objective: To determine the clinical profile of COVID-19 inpatients who were vaccinated prior to hospitalization and to compare the risk factors for death and the 28-day survival rate of between those inpatients vaccinated with one, two, or three doses and unvaccinated COVID-19 inpatients. Methods: This was a retrospective observational cohort study involving COVID-19 patients admitted to a referral hospital in the city of Recife, Brazil, between July of 2020 and June of 2022. Results: The sample comprised 1,921 inpatients, 996 of whom (50.8%) were vaccinated prior to hospitalization. After adjusting the mortality risk for vaccinated patients, those undergoing invasive mechanical ventilation (IMV) had the highest mortality risk (adjusted OR [aOR] = 7.4; 95% CI, 3.8-14.1; p < 0.001), followed by patients > 80 years of age (aOR = 7.3; 95% CI, 3.4-15.4; p < 0.001), and those needing vasopressors (aOR = 5.6; 95% CI, 2.9-10.9; p < 0.001). After adjusting the mortality risk for all patients, having received three vaccine doses (aOR = 0.06; 95% CI, 0.03-0.11; p < 0.001) was the most important protective factor against death. There were progressive benefits of vaccination, reducing the frequency of ICU admissions, use for IMV, and death (respectively, from 44.9%, 39.0% and 39.9% after the first dose to 16.7%, 6.2% and 4.4% after the third dose), as well as significant improvements in survival after each subsequent dose (p < 0.001). Conclusions: Vaccines were effective in reducing illness severity and death in this cohort of COVID-19 inpatients, and the administration of additional doses conferred them with accumulative vaccine protection.

9 August 2024 in Clinical Obesity
Verified
Journal Article
Closed access
GSGabrielle Ribeiro Sena
Gabrielle Ribeiro Sena
TLTiago Pessoa Ferreira de Lima
Tiago Pessoa Ferreira de Lima
MSMichelle Lima de Carvalho Silva
Michelle Lima de Carvalho Silva
PSPaloma Gomes Tavares Sette
Paloma Gomes Tavares Sette
GCGabriela Carla dos Santos Costa
Gabriela Carla dos Santos Costa
GCGuilherme Jorge Costa
Guilherme Jorge Costa

1 January 2024 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
MCMariana Lúcia Correia Ramos Costa
Mariana Lúcia Correia Ramos Costa
MFMarcela Rezende Franco
Marcela Rezende Franco
CCCamila Menezes Costa
Camila Menezes Costa
GCGabriela Carla dos Santos Costa
Gabriela Carla dos Santos Costa
MNMaria Luiza de Queiroz Neta
Maria Luiza de Queiroz Neta
GCGuilherme Jorge Costa
Guilherme Jorge Costa
Resumo Objectives: to determine the clinical and epidemiological profile of the long post-COVID syndrome (LPCS) and the quality of life among female survivors compared to males after hospitalization for COVID-19 in the city of Recife, Brazil. Methods: a prospective cohort study analyzed demographic and clinical data during hospitalization, as well as LPCS and the quality of life questionnairewhereasdata was collected by telecare at three, sixand 12 months after hospital discharge. Logistic regression was used to explore the association between variables and each dimension of the questionnaire. Results: 887 patients were included. At the end of three, sixand 12 months, women were more frequently reported with LPCS (p<0.001). Regarding quality of life, women tended to worsen over time in all domains compared to men: mobility domain (28.4% versus 9.3%, p<0.05), personal care (14.8% versus 5.6%; p<0.05), usual activities (30.8% versus 13.1%, p < 0.05), pain/discomfort (29% versus 16.9%, p<0.05) and anxiety/depression (43.8% versus 33.3%, p<0.05). Conclusion: the frequency of LPCS increased and the quality of life worsened with both genders until the first year after hospital discharge, especially in women.

1 January 2024 in Revista Brasileira de Saúde Materno Infantil
Verified
Journal Article
Open access
PDF file
MCMariana Lúcia Correia Ramos Costa
Mariana Lúcia Correia Ramos Costa
MFMarcela Rezende Franco
Marcela Rezende Franco
CCCamila Menezes Costa
Camila Menezes Costa
GCGabriela Carla dos Santos Costa
Gabriela Carla dos Santos Costa
MNMaria Luiza de Queiroz Neta
Maria Luiza de Queiroz Neta
GCGuilherme Jorge Costa
Guilherme Jorge Costa
Objectives: to determine the clinical and epidemiological profile of the long post-COVID syndrome (LPCS) and the quality of life among female survivors compared to males after hospitalization for COVID-19 in the city of Recife, Brazil. Methods: a prospective cohort study analyzed demographic and clinical data during hospitalization, as well as LPCS and the quality of life questionnairewhereasdata was collected by telecare at three, sixand 12 months after hospital discharge. Logistic regression was used to explore the association between variables and each dimension of the questionnaire. Results: 887 patients were included. At the end of three, sixand 12 months, women were more frequently reported with LPCS (p<0.001). Regarding quality of life, women tended to worsen over time in all domains compared to men: mobility domain (28.4% versus 9.3%, p<0.05), personal care (14.8% versus 5.6%; p<0.05), usual activities (30.8% versus 13.1%, p < 0.05), pain/discomfort (29% versus 16.9%, p<0.05) and anxiety/depression (43.8% versus 33.3%, p<0.05). Conclusion: the frequency of LPCS increased and the quality of life worsened with both genders until the first year after hospital discharge, especially in women.